Common Stock
- Symbol
- WINT
- Exchange
- Not supplied
- Classification
- COMMON
Current Report · Items 5.02 · 8-K
Windtree Therapeutics, Inc.
WINTOTCEQUITYCurrent
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January 5, 2026, Eric L. Curtis resigned as President and Chief Operating Officer of Windtree Therapeutics, Inc., effective immediately.
Company context
We are a diversified company with several divisions and focused on seeking partnerships and becoming a revenue-generating company through various initiatives. Our operations include pharmaceutical manufacturing as a sourcing agent for Evofem Biosciences, Inc. (“Evofem”), and biotechnology.
Current securities
Historical securities (7)
WINTNASDAQ · EQUITY · Historical · closed Aug 20, 2025WINTOTC · EQUITY · Historical · closed Dec 22, 2017WINTOTC · EQUITY · Historical · closed Apr 29, 2020WINTOTC · EQUITY · Historical · closed Dec 22, 2017WINTDOTC · EQUITY · Historical · closed Jan 22, 2018WINTDOTC · EQUITY · Historical · closed May 20, 2020WINTWOTC · WARRANT · Historical · closed Mar 25, 2026
Registered securities in this filing
Windtree Therapeutics, Inc. · 8-K · Filed 2026-01-07
Disclosure sections
Item 5.02Item 5.02 - Departure/Election of Directors
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On January 5, 2026, Eric L. Curtis resigned as President and Chief Operating Officer of Windtree Therapeutics, Inc., effective immediately.